Statin/fibrate combination in patients with metabolic syndrome or diabetes: evaluating the risks of pharmacokinetic drug interactions

By Davidson Michael H  

Expert Opinion on Drug Safety, Vol. 5, Iss. 1, 2006-01 ,pp. : 145-156

Informa Healthcare

Access to resources Recommend Favorite

The Relationship between Adipokines, Metabolic Parameters and Insulin Resistance in Patients with Metabolic Syndrome and Type 2 Diabetes

By Lee JM   Kim SR   Yoo SJ   Hong OK   Son HS   Chang SA  

The Journal of International Medical Research, Vol. 37, Iss. 6, 2009-11 ,pp. : 1803-1812

Field House Publishing

Access to resources Recommend Favorite

Combination lipid therapy in type 2 diabetes mellitus

By Vergèès Bruno  

Expert Opinion on Pharmacotherapy, Vol. 12, Iss. 9, 2011-06 ,pp. : 1393-1403

Informa Healthcare

Access to resources Recommend Favorite

A combination of insulin and metformin improves hepatic steatosis in patients with type 2 diabetes mellitus

By  

Inpharma, Vol. 1, Iss. 1600, 2007-01 ,pp. : 14-14

Adis International

Access to resources Recommend Favorite

Efficacy and Safety of Fenofibric Acid Co-Administered with Low- or Moderate-Dose Statin in Patients with Mixed Dyslipidemia and Type 2 Diabetes Mellitus: Results of a Pooled Subgroup Analysis from Three Randomized, Controlled, Double-Blind Trials

By Jones Peter H.  

American Journal of Cardiovascular Drugs, Vol. 10, Iss. 2, 2010-04 ,pp. : 73-84

Adis International

Access to resources Recommend Favorite